BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8218283)

  • 1. Boundary of the autoinhibitory region of smooth muscle myosin light-chain kinase.
    Yano K; Araki Y; Hales SJ; Tanaka M; Ikebe M
    Biochemistry; 1993 Nov; 32(45):12054-61. PubMed ID: 8218283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Location of the inhibitory region of smooth muscle myosin light chain kinase.
    Ikebe M; Maruta S; Reardon S
    J Biol Chem; 1989 Apr; 264(12):6967-71. PubMed ID: 2708351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudosubstrate sequence may not be critical for autoinhibition of smooth muscle myosin light chain kinase.
    Tanaka M; Ikebe R; Matsuura M; Ikebe M
    EMBO J; 1995 Jun; 14(12):2839-46. PubMed ID: 7796810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolytic cleavage sites in smooth muscle myosin-light-chain kinase and their relation to structural and regulatory domains.
    Pearson RB; Ito M; Morrice NA; Smith AJ; Condron R; Wettenhall RE; Kemp BE; Hartshorne DJ
    Eur J Biochem; 1991 Sep; 200(3):723-30. PubMed ID: 1915344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the pseudosubstrate sequence in smooth muscle myosin light chain kinase thermal stability.
    Faux MC; Pearson RB; Mitchelhill KI; Kemp BE
    J Biol Chem; 1993 Jun; 268(17):12484-91. PubMed ID: 8509388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure and function of the actin-binding domain of myosin light chain kinase of smooth muscle.
    Ye LH; Hayakawa K; Kishi H; Imamura M; Nakamura A; Okagaki T; Takagi T; Iwata A; Tanaka T; Kohama K
    J Biol Chem; 1997 Dec; 272(51):32182-9. PubMed ID: 9405419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent peptide inhibitors of smooth muscle myosin light chain kinase: mapping of the pseudosubstrate and calmodulin binding domains.
    Foster CJ; Johnston SA; Sunday B; Gaeta FC
    Arch Biochem Biophys; 1990 Aug; 280(2):397-404. PubMed ID: 2369131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of inhibition of smooth muscle myosin light chain kinase by synthetic peptide analogs of the regulatory site.
    Ikebe M
    Biochem Biophys Res Commun; 1990 Apr; 168(2):714-20. PubMed ID: 2334433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definition of the inhibitory domain of smooth muscle myosin light chain kinase by site-directed mutagenesis.
    Ito M; Guerriero V; Chen XM; Hartshorne DJ
    Biochemistry; 1991 Apr; 30(14):3498-503. PubMed ID: 2012809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary structure required for the inhibition of smooth muscle myosin light chain kinase.
    Ikebe M; Reardon S; Fay FS
    FEBS Lett; 1992 Nov; 312(2-3):245-8. PubMed ID: 1426258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The carboxyl terminus of the smooth muscle myosin light chain kinase is expressed as an independent protein, telokin.
    Gallagher PJ; Herring BP
    J Biol Chem; 1991 Dec; 266(35):23945-52. PubMed ID: 1748667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophosphorylation of smooth muscle myosin light chain kinase at its regulatory domain.
    Tokui T; Ando S; Ikebe M
    Biochemistry; 1995 Apr; 34(15):5173-9. PubMed ID: 7711037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of amino acids essential for calmodulin binding and activation of smooth muscle myosin light chain kinase.
    Bagchi IC; Huang QH; Means AR
    J Biol Chem; 1992 Feb; 267(5):3024-9. PubMed ID: 1737757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional role of the C-terminal domain of smooth muscle myosin light chain kinase on the phosphorylation of smooth muscle myosin.
    Numata T; Katoh T; Yazawa M
    J Biochem; 2001 Mar; 129(3):437-44. PubMed ID: 11226884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory mechanism of Dictyostelium myosin light chain kinase A.
    Tokumitsu H; Hatano N; Inuzuka H; Ishikawa Y; Uyeda TQ; Smith JL; Kobayashi R
    J Biol Chem; 2004 Jan; 279(1):42-50. PubMed ID: 14570871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of smooth muscle myosin light chain kinase activity by a monoclonal antibody which recognizes the calmodulin-binding region.
    Araki Y; Ikebe M
    Biochem J; 1991 May; 275 ( Pt 3)(Pt 3):679-84. PubMed ID: 1710106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity labelling of smooth-muscle myosin light-chain kinase with 5'-[p-(fluorosulphonyl)benzoyl]adenosine.
    Komatsu H; Ikebe M
    Biochem J; 1993 Nov; 296 ( Pt 1)(Pt 1):53-8. PubMed ID: 8250857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory and structural motifs of chicken gizzard myosin light chain kinase.
    Olson NJ; Pearson RB; Needleman DS; Hurwitz MY; Kemp BE; Means AR
    Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2284-8. PubMed ID: 2315320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smooth muscle myosin light chain kinase, supramolecular organization, modulation of activity, and related conformational changes.
    Filenko AM; Danilova VM; Sobieszek A
    Biophys J; 1997 Sep; 73(3):1593-606. PubMed ID: 9284326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Domain organization of chicken gizzard myosin light chain kinase deduced from a cloned cDNA.
    Guerriero V; Russo MA; Olson NJ; Putkey JA; Means AR
    Biochemistry; 1986 Dec; 25(26):8372-81. PubMed ID: 3030394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.